Exact Mass: 673.2747644

Exact Mass Matches: 673.2747644

Found 46 metabolites which its exact mass value is equals to given mass value 673.2747644, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Ustiloxin A

2-Amino-5-({4-[(carboxymethyl)-C-hydroxycarbonimidoyl]-3-ethyl-6,9,11,15-tetrahydroxy-3-methyl-10-(methylamino)-7-(propan-2-yl)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-yl}sulphinyl)-4-hydroxypentanoic acid

C28H43N5O12S (673.2628798000001)

Ustiloxin A is found in cereals and cereal products. Ustiloxin A is isolated from the false smut balls caused by Ustilaginoidea virens on rice. Isolated from the false smut balls caused by Ustilaginoidea virens on rice. Ustiloxin A is found in cereals and cereal products.

triferuloyl spermidine

N1,N5,N10-triferuloyl spermidine

C37H43N3O9 (673.2999148)

F1alpha

2-amino-3-{[3-acetamido-6-({[3-acetamido-4-hydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}methyl)-4,5-dihydroxyoxan-2-yl]oxy}propanoic acid

C25H43N3O18 (673.2541498)

triferuloyl spermidine

N-{3-[N-(4-{[1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}butyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamido]propyl}-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidate

C37H43N3O9 (673.2999148)

Triferuloyl spermidine belongs to hydroxycinnamic acids and derivatives class of compounds. Those are compounds containing an cinnamic acid (or a derivative thereof) where the benzene ring is hydroxylated. Triferuloyl spermidine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Triferuloyl spermidine can be found in a number of food items such as japanese chestnut, jicama, lovage, and hickory nut, which makes triferuloyl spermidine a potential biomarker for the consumption of these food products.

Pro Trp Trp Trp

(2S)-3-(1H-indol-3-yl)-2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]propanoic acid

C38H39N7O5 (673.3012524)

Trp Pro Trp Trp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C38H39N7O5 (673.3012524)

Trp Trp Pro Trp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanoic acid

C38H39N7O5 (673.3012524)

Trp Trp Trp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

C38H39N7O5 (673.3012524)

Ustiloxin A

2-amino-5-{4-[(carboxymethyl)carbamoyl]-3-ethyl-11,15-dihydroxy-3-methyl-10-(methylamino)-6,9-dioxo-7-(propan-2-yl)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),12,14-triene-13-sulfinyl}-4-hydroxypentanoic acid

C28H43N5O12S (673.2628798000001)

SNAG-delta5-CA

3beta-sulfooxy-7beta-N-acetylglucosaminyl-5-cholen-24-oic acid

C32H51NO12S (673.3131806000001)

Ac-Val-Glu-Ile-Asp-AMC

C32H43N5O11 (673.2958928)

5-DMT-Bz-rA

C38H35N5O7 (673.2536359999999)

5'-O-DMT-Bz-rA is an intermediate for cyclic di-nucleotide compounds?synthesis[1].

Detorubicin

C33H39NO14 (673.2370434)

Methylprednisolone suleptanate

sodium,2-[[8-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-8-oxooctanoyl]-methylamino]ethanesulfonate

C33H48NNaO10S (673.2896468)

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid

Nifalatide

C30H39N7O9S (673.2529844000001)

Dihydro-alpha-ergocryptine mesylate

C33H47N5O8S (673.3145182000001)

N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

Acetyl-methanofuran b

C31H39N5O12-2 (673.2595094000001)

alpha-N-acetylneuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine(1-)

C25H41N2O19- (673.2303416)

alpha-NeuNAc-(2->3)-beta-D-Gal-(1->3)-D-GalNAc(1-)

C25H41N2O19- (673.2303416)

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine

C25H41N2O19- (673.2303416)

Dihydro-beta-ergocryptine methanesulfonate

C33H47N5O8S (673.3145182000001)

N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-thiophenesulfonamide

N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-thiophenesulfonamide

C34H47N3O7S2 (673.2855272)

N-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-thiophenesulfonamide

N-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-thiophenesulfonamide

C34H47N3O7S2 (673.2855272)

[(1S,2S,3R,4R,5S,6S,7S,8R,13R,14R,16S,17S,18R)-8,14-diacetyloxy-5,7-dihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-methyl-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] benzoate

C35H47NO12 (673.3098102)

Ustiloxin

C28H43N5O12S (673.2628798000001)

N1,N5,N10-triferuloyl spermidine

C37H43N3O9 (673.2999148)

Dihydro-beta-ergocryptine mesylate

C32H43N5O5. CH4SO3 (673.3145182000001)

PS O-26:6;O3

C32H52NO12P (673.3226962)

PS P-18:1/8:4;O3

C32H52NO12P (673.3226962)

PS 18:2/8:3;O2

C32H52NO12P (673.3226962)

PS 18:3/7:3;O3

C31H48NO13P (673.2863127999999)

PS 18:3/8:2;O2

C32H52NO12P (673.3226962)

PS 18:4/7:2;O3

C31H48NO13P (673.2863127999999)

PS 18:4/8:1;O2

C32H52NO12P (673.3226962)

PS 22:4/4:1;O2

C32H52NO12P (673.3226962)

PS 25:6;O3

C31H48NO13P (673.2863127999999)

PS 26:5;O2

C32H52NO12P (673.3226962)

ST 27:7;O7;HexNAc

C35H47NO12 (673.3098102)

2,3-dihydroxy-n-(3-{n-[3-({hydroxy[2-(2-hydroxyphenyl)-5-methyl-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)propyl]-1-[2-(2-hydroxyphenyl)-5-methyl-4,5-dihydro-1,3-oxazol-4-yl]formamido}propyl)benzenecarboximidic acid

2,3-dihydroxy-n-(3-{n-[3-({hydroxy[2-(2-hydroxyphenyl)-5-methyl-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)propyl]-1-[2-(2-hydroxyphenyl)-5-methyl-4,5-dihydro-1,3-oxazol-4-yl]formamido}propyl)benzenecarboximidic acid

C35H39N5O9 (673.2747644)

n-{3-[(2s,5s,17s)-3,6,9,12,15,18-hexahydroxy-5-[3-(n-hydroxyacetamido)propyl]-17-[3-(n-hydroxyformamido)propyl]-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]propyl}-n-hydroxyacetamide

n-{3-[(2s,5s,17s)-3,6,9,12,15,18-hexahydroxy-5-[3-(n-hydroxyacetamido)propyl]-17-[3-(n-hydroxyformamido)propyl]-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]propyl}-n-hydroxyacetamide

C26H43N9O12 (673.3031038)

2,3-dihydroxy-n-{3-[n-(3-{[hydroxy({5-methyl-2-[(1z)-6-oxocyclohexa-2,4-dien-1-ylidene]-1,3-oxazolidin-4-yl})methylidene]amino}propyl)-1-[(4s,5r)-5-methyl-2-[(1z)-6-oxocyclohexa-2,4-dien-1-ylidene]-1,3-oxazolidin-4-yl]formamido]propyl}benzenecarboximidic acid

2,3-dihydroxy-n-{3-[n-(3-{[hydroxy({5-methyl-2-[(1z)-6-oxocyclohexa-2,4-dien-1-ylidene]-1,3-oxazolidin-4-yl})methylidene]amino}propyl)-1-[(4s,5r)-5-methyl-2-[(1z)-6-oxocyclohexa-2,4-dien-1-ylidene]-1,3-oxazolidin-4-yl]formamido]propyl}benzenecarboximidic acid

C35H39N5O9 (673.2747644)